---
schema_version: '1.0'
id: news-20260902-861992
title: NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept
  Study in Acute Spinal Cord Injury
url: https://www.finanznachrichten.de/nachrichten-2026-09/69473786-novago-therapeutics-closes-usd-30-million-series-b-financing-to-advance-proof-of-concept-study-in-acute-spinal-cord-injury-008.htm
url_hash: 8619928e7c2d6899153f487b4e4b402f42b31c65d7c6330efc39a63feafba4ed
canonical_url: https://www.finanznachrichten.de/nachrichten-2026-09/69473786-novago-therapeutics-closes-usd-30-million-series-b-financing-to-advance-proof-of-concept-study-in-acute-spinal-cord-injury-008.htm
source: www.finanznachrichten.de
category: news/tech
category_raw: it_general
region: null
tags:
- it
- it_general
- it_tech
lang: null
published_at: null
fetched_at: '2026-09-02T11:17:03.073396Z'
updated_at: '2026-09-02T11:49:43Z'
status: published
content_hash: null
content_changed_at: null
license_note: link-only
summary: null
summary_source: null
summary_en: null
summary_omitted_reason: license_restricted
redistribution: false
keywords_en:
- Acute
- Advance
- artificial intelligence
- Closes
- Cord
- Financing
- iCE40Series
- Injury
- it
- IT / Forbes JAPAN (2026年9月1日
- it_general
- it_tech
- Million
- Millions_of_users
- NovaGo
- NovaGo_Therapeutics
- Proof-of-Concept
- Series
- Spinal
- Study
- technology
- Therapeutics
- USD
- USDA
entities_en:
- name: iCE40Series
  type: artifact
- name: IT / Forbes JAPAN (2026年9月1日
  type: content
- name: Millions_of_users
  type: person
- name: NovaGo_Therapeutics
  type: organization
- name: USDA
  type: organization
topics_en:
- artificial intelligence
- technology
numeric_facts: []
entities:
- name: IT / Forbes JAPAN (2026年9月1日
  type: content
- name: NovaGo_Therapeutics
  type: organization
- name: USDA
  type: organization
- name: Millions_of_users
  type: person
- name: iCE40Series
  type: artifact
key_facts: []
related: []
related_auto:
- name: Neurimmune
  type: organization
  weight: 1.0
- name: Acute_Spinal_Cord_Injury
  type: event
  weight: 1.0
- name: Nogo-A
  type: concept
  weight: 1.0
- name: CHF_24_million
  type: data
  weight: 1.0
- name: Pureos
  type: organization
  weight: 1.0
computed_at: '2026-09-02T11:49:40Z'
---

# NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury

## TL;DR
（要約なし・原文はリンク先を参照 / No summary available; see the source link.）

## Key Points
- it / it_general / it_tech

## Details
(本文なし。リンク先参照)

## Source
元記事: [NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury](https://www.finanznachrichten.de/nachrichten-2026-09/69473786-novago-therapeutics-closes-usd-30-million-series-b-financing-to-advance-proof-of-concept-study-in-acute-spinal-cord-injury-008.htm)